All Stories

  1. Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction
  2. Evolution of CRISPR-enabled biosensors for amplification-free nucleic acid detection
  3. Bioinspired and biomimetic cancer-cell-derived membrane nanovesicles for preclinical tumor-targeted nanotheranostics
  4. Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma
  5. Engineered Liposomes in Interventional Theranostics of Solid Tumors
  6. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
  7. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
  8. Hydrogels for RNA delivery
  9. mRNA therapy at the convergence of genetics and nanomedicine
  10. Biopolymeric Coatings for Local Release of Therapeutics from Biomedical Implants
  11. Technological challenges of biomembrane-coated top-down cancer nanotherapy
  12. ‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
  13. Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids
  14. Nucleic acid-based therapy for brain cancer: Challenges and strategies
  15. Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer
  16. Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics
  17. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  18. Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
  19. Nanodelivery of nucleic acids
  20. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  21. Bioinspired soft nanovesicles for site‐selective cancer imaging and targeted therapies
  22. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019
  23. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  24. Prodrug Polymeric Nanoconjugates Encapsulating Gold Nanoparticles for Enhanced X‐Ray Radiation Therapy in Breast Cancer
  25. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  26. Machine learning for next-generation nanotechnology in healthcare
  27. Child Mortality Trends and Targets: GBD 2019 Findings
  28. Nanomedicine-based strategies to target and modulate the tumor microenvironment
  29. Facts and Figures on Materials Science and Nanotechnology Progress and Investment
  30. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression
  31. CRISPR Systems for COVID-19 Diagnosis
  32. Ultrahigh Penetration and Retention of Graphene Quantum Dot Mesoporous Silica Nanohybrids for Image Guided Tumor Regression
  33. Controlled delivery of gold nanoparticle-coupled miRNA therapeuticsviaan injectable self-healing hydrogel
  34. Revisiting gene delivery to the brain: silencing and editing
  35. “Swallowing the doctor”: an interview with João Conde about the future of nanomedicine
  36. Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies
  37. Why Go NANO on COVID-19 Pandemic?
  38. Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic
  39. Tetrazine Carbon Nanotubes for Pretargeted In Vivo “Click‐to‐Release” Bioorthogonal Tumour Imaging
  40. Nanotechnology-based disinfectants and sensors for SARS-CoV-2
  41. Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near‐infrared light mediated cancer therapy
  42. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation
  43. Composite Hydrogels: Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells (Adv. Healthcare Mater. 4/2020)
  44. Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells
  45. Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome
  46. Gastric Parietal Cell and Intestinal Goblet Cell Secretion: a Novel Cell-Mediated In Vivo Metal Nanoparticle Metabolic Pathway Enhanced with Diarrhea Via Chinese Herbs
  47. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression
  48. Cisplatin-Triggered Bioorthogonal Decaging of Amide Bonds for Targeted-Drug Activation in vivo
  49. Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
  50. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
  51. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells
  52. Displaying biofunctionality on materials through templated self-assembly
  53. Handbook of Nanomaterials for Cancer Theranostics
  54. Fullerene: biomedical engineers get to revisit an old friend
  55. Smart NIR linear and nonlinear optical nanomaterials for cancer theranostics: Prospects in photomedicine
  56. Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections
  57. Designing Hydrogels for On-Demand Therapy
  58. 3D hydrogel scaffold doped with 2D graphene materials for biosensors and bioelectronics
  59. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly
  60. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging
  61. Local microRNA delivery targets Palladin and prevents metastatic breast cancer
  62. Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns
  63. Revisiting the ‘One Material Fits All’ Rule for Cancer Nanotherapy
  64. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications
  65. Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research
  66. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
  67. Gold nanoprisms as a hybrid in vivo cancer theranostic platform for in situ photoacoustic imaging, angiography, and localized hyperthermia
  68. Dual-Color Emissive Upconversion Nanocapsules for Differential Cancer Bioimaging In Vivo
  69. Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
  70. Dual-sensitive hydrogel composite for local release and selective uptake of chemotherapy for the treatment of breast cancer
  71. RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?
  72. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment
  73. The Golden Age in Cancer Nanobiotechnology: Quo Vadis?
  74. Investigating the role of shape on the biological impact of gold nanoparticles in vitro
  75. Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles
  76. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects
  77. 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  78. Personalized Medicine: Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment (Adv. Healthcare Mater. 11/2015)
  79. Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis
  80. Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
  81. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
  82. Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment
  83. The next generation of smart gold nanobeacons: nanotheranostics is ready for prime time
  84. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance
  85. Are RNAi and miRNA therapeutics truly dead?
  86. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing
  87. Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: The jack-of-all-trades in cancer nanotheranostics?
  88. A promising road with challenges: where are gold nanoparticles in translational research?
  89. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
  90. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
  91. Polyurea dendrimer for efficient cytosolic siRNA delivery
  92. Multifunctional Gold Nanocarriers for Cancer Theranostics: From Bench to Bedside and Back Again?
  93. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models
  94. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
  95. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events
  96. Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
  97. Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles
  98. Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
  99. Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair
  100. Gold-nanobeacons for real-time monitoring of RNA synthesis
  101. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles
  102. Noble Metal Nanoparticles for Biosensing Applications
  103. Nanophotonics for Molecular Diagnostics and Therapy Applications
  104. Alloy metal nanoparticles for multicolor cancer diagnostics
  105. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles
  106. Use of cyclodextrins as scavengers of inhibitory photo-products in light controlled in vitro synthesis of RNA
  107. RNA quantification using gold nanoprobes - application to cancer diagnostics
  108. Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study